Health Catalyst, Inc.
NASDAQ:HCATMedical - Healthcare Information Services
-$0.04 today
- Market cap
- $98.24M
- Beta
- 1.66
- P/E (TTM)
- -0.5
- EPS (TTM)
- -$3.65
Volume 0.27M
Average 1.24M
HCAT Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Health Catalyst, Inc.NASDAQ: HCAT
Other Non-Cash Items · Q1 FY2026 · quarter ended Mar 2026
Other non-cash items grows, but more slowly than its trailing trend
Q1 FY2026 other non-cash items of $101.09M rose 6434.3% year over year, behind the +13309.8% change in trailing-twelve-month other non-cash items. Sequentially, it rose 22.1% from the prior quarter. Over 3 fiscal years it compounded at +795.2% a year.
Context
- Other non-cash items amounted to 37.4% of revenue in FY2025, up 36.3 pp from a year earlier.
- Other non-cash items increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +6434.3% toward the trailing-twelve-month pace of +13309.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- 116.22M USD
- Year-over-year change
- +3667.4%
- 4-year CAGR
- +40.4%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 116.22M | +3667.4% |
| FY2024 | 2024-12-31 | 3.09M | +311.3% |
| FY2023 | 2023-12-31 | 750K | +363.0% |
| FY2022 | 2022-12-31 | 162K | -99.5% |
| FY2021 | 2021-12-31 | 29.93M | — |
Other Non-Cash Items vs competitors
How HCAT compares with its peers on the latest reported figures
- HCAT's LTM Mar 2026 other non-cash items of $215.76M is the largest of the 11 companies compared; the peer median is $4.06M.
- Its year-over-year change of +13309.8% is the highest of 11, against a peer median of +33.1%.
- Other non-cash items amounts to 71.3% of revenue for HCAT, versus a peer median of 8.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $215.76M | +13309.8% | +795.2% | 71.3% | |
| LTM Mar 2026 | $109.56M | +9602.3% | +165.2% | 1142.6% | |
| LTM Mar 2026 | $24.36M | +579.5% | +34.3% | 217.5% | |
| LTM Dec 2025 | $16.35M | +84.5% | -30.6% | 125.6% | |
| LTM Mar 2026 | $6.22M | +147.8% | +30.0% | 5.3% | |
| LTM Mar 2026 | $5.22M | -85.4% | -8.1% | 11.8% | |
| LTM Mar 2026 | $2.91M | -18.3% | +10.3% | 1291.1% | |
| LTM Mar 2026 | $1.33M | -719.1% | — | 1.9% | |
| LTM Mar 2026 | $969K | -33.9% | +16.7% | 3.0% | |
| LTM Mar 2026 | $832K | +121.2% | -29.1% | 5.0% | |
| LTM Mar 2026 | $27K | -99.8% | — | 0.2% | |
| Peer median (excluding HCAT) | $4.06M | +33.1% | +13.5% | 8.5% | |
Competitors are the stored peer set for HCAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (153.21M) | (137.4M) | (118.15M) | (69.5M) | (177.97M) |
| Depreciation & Amortization | 37.53M | 48.3M | 42.22M | 41.43M | 50.5M |
| Deferred Income Tax | (7.13M) | (4.52M) | 8K | 77K | 81K |
| Stock-Based Compensation | 65.15M | 72.1M | 55.76M | 40.13M | 27.01M |
| Change in Working Capital | 4.62M | (13.91M) | (13.67M) | (660K) | (15.11M) |
| Accounts Receivables | 102K | 788K | (13.66M) | 4.28M | (1.81M) |
| Inventory | (8.33M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 5.2M | (4.7M) | 4.87M | 5.58M | (11.51M) |
| Other Working Capital | 7.64M | (9.99M) | (4.88M) | (10.52M) | (1.79M) |
| Other Non-Cash Items | 29.93M | 162K | 750K | 3.09M | 116.22M |
| Operating Cash Flow | (23.12M) | (35.27M) | (33.08M) | 14.56M | 731K |
| Capital Expenditures | (18.47M) | (17.41M) | (14.31M) | (16.4M) | (968K) |
| Acquisitions (Net) | (46.76M) | (27.85M) | (11.39M) | (80.28M) | (41.11M) |
| Purchases of Investments | (261.36M) | (308.96M) | (290.84M) | (168.31M) | (65.13M) |
| Sales of Investments | 186.89M | 315.17M | 336.8M | 242.07M | 163.95M |
| Other Investing Activities | 22K | (15.22M) | (13.04M) | (14.77M) | (20.54M) |
| Investing Cash Flow | (139.68M) | (39.02M) | 20.29M | (22.9M) | 36.19M |
| Debt Repayment | 0 | 0 | 0 | 151.32M | (232.29M) |
| Common Stock Issued | 245.18M | 0 | 0 | 2.58M | 1.51M |
| Common Stock Repurchased | 0 | (8.39M) | (1.81M) | 0 | (5M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 18.9M | 5.78M | 4.54M | (2.15M) | 0 |
| Financing Cash Flow | 264.08M | (2.61M) | 2.73M | 151.75M | (235.78M) |
| Effect of Forex Changes | (10K) | (11K) | 21K | (34K) | 27K |
| Net Change in Cash | 101.27M | (76.92M) | (10.04M) | 143.37M | (198.83M) |
| Free Cash Flow | (41.59M) | (52.68M) | (47.39M) | (1.84M) | (237K) |
Health Catalyst, Inc.
NASDAQ:HCAT
Intrinsic Alpha fair value
Locked
Current Price
$1.29
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.